Latest Lupus news
Obinutuzumab Efficacious for Renal Response in Lupus Nephritis
posted February 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
posted February 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Atherosclerotic CVD Up in Association With Cutaneous Lupus Erythematosus
posted January 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Scientists Spot Cause of Lupus, Way to Reverse It
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder 
Patients With Lupus Have Increased Risk of CKD, Mortality 
Lupus Low Disease Activity State Attainable in Lupus Nephritis 
Pericarditis Recurrence Occurs in About 20 Percent of Patients With Lupus 
Air Pollutant Exposure Linked to Increased Risk for Incident Lupus Monthly Specialist Briefings
Stay Connected
